Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization study
Author(s) -
Zhiyan Liu,
Qiufen Xie,
Qian Xiang,
Hanxu Zhang,
Guangyan Mu,
Zinan Zhao,
Hu Tao-Tao,
Tingting Wu,
Na Wang,
Jinhua Zhang,
Yan Qian,
Shuang Zhou,
Zining Wang,
Jie Jiang,
Yatong Zhang,
Hongtao Song,
Yimin Cui
Publication year - 2020
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt-20-564
Subject(s) - medicine , rivaroxaban , dabigatran , population , drug , logistic regression , pharmacodynamics , pharmacology , warfarin , pharmacokinetics , atrial fibrillation , environmental health
The data of anti-FXa-IIa activity detection in Asian population is insufficient, and its potential role for drug adherence evaluation in patients with direct oral anticoagulants (DOACs) remains unclear. This study carried out multi-center anti-FXa-IIa activity detection in Asian, aiming to explore its applicability in Asian population and find its role in adherence evaluation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom